RecruitingNCT06217874
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
Sponsor
Mayo Clinic
Enrollment
2,000 participants
Start Date
Jun 5, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
This study is being done to create a resource of samples and information that can be used to improve our understanding of the development, progression and treatment of recurrent or metastatic breast cancer or male breast cancer.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This is not a treatment trial — it is a registry study that collects tissue samples, blood samples, and medical data from patients with pancreatic cysts or pancreatic cancer. Researchers will use these samples to better understand how pancreatic cancer develops and to look for early detection markers.
**You may be eligible if...**
- You have been diagnosed with a pancreatic cyst or pancreatic cancer
- You are 18 or older
- You are willing to provide tissue or blood samples and share your medical information
- You are able to give informed consent
**You may NOT be eligible if...**
- You are unable or unwilling to provide samples or consent
- You have a condition that the study team determines would prevent safe participation
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06217874
Related Trials
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
NCT045217641 location
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
NCT053726407 locations
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
NCT072850441 location
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
NCT0618475011 locations
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
NCT061308261 location